Cargando…

Combinational PRR Agonists in Liposomal Adjuvant Enhances Immunogenicity and Protective Efficacy in a Tuberculosis Subunit Vaccine

Bacillus Calmette-Guerin (BCG) is the only licensed vaccine to prevent children from tuberculosis (TB), whereas it cannot provide effective protection for adults. Our previous work showed a novel vaccine candidate, liposomal adjuvant DMT emulsified with a multistage antigen CMFO, could protect mice...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hao, Ling, Wu, Yaqi, Zhang, Yandi, Zhou, Zijie, Lei, Qing, Ullah, Nadeem, Banga Ndzouboukou, Jo-Lewis, Lin, Xiaosong, Fan, Xionglin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7561437/ https://www.ncbi.nlm.nih.gov/pubmed/33117374 http://dx.doi.org/10.3389/fimmu.2020.575504

Ejemplares similares

Differential Immunogenicity and Protective Efficacy Elicited by MTO- and DMT-Adjuvanted CMFO Subunit Vaccines against Mycobacterium tuberculosis Infection
por: Ullah, Nadeem, et al.
Publicado: (2020)

Enhanced tuberculosis clearance through the combination treatment with recombinant adenovirus-mediated granulysin delivery
por: Hao, Ling, et al.
Publicado: (2020)

Immune Evasive Effects of SARS-CoV-2 Variants to COVID-19 Emergency Used Vaccines
por: Zhang, Yandi, et al.
Publicado: (2021)

Label-Free Comparative Proteomics of Differentially Expressed Mycobacterium tuberculosis Protein in Rifampicin-Related Drug-Resistant Strains
por: Ullah, Nadeem, et al.
Publicado: (2021)

Formulation in DDA-MPLA-TDB Liposome Enhances the Immunogenicity and Protective Efficacy of a DNA Vaccine against Mycobacterium tuberculosis Infection
por: Tian, Maopeng, et al.
Publicado: (2018)

Kinetics of Neutralizing Antibody Response Underscores Clinical COVID-19 Progression
por: Lei, Qing, et al.
Publicado: (2021)

A Multistage Subunit Vaccine Effectively Protects Mice Against Primary Progressive Tuberculosis, Latency and Reactivation
por: Ma, Jilei, et al.
Publicado: (2017)

Enhanced immunogenicity of the tuberculosis subunit Rv0572c vaccine delivered in DMT liposome adjuvant as a BCG-booster
por: Mao, Lirong, et al.
Publicado: (2022)

A New Adjuvant MTOM Mediates Mycobacterium tuberculosis Subunit Vaccine to Enhance Th1-Type T Cell Immune Responses and IL-2(+) T Cells
por: Yu, Qi, et al.
Publicado: (2017)

Targeting Pattern Recognition Receptors (PRR) for Vaccine Adjuvantation: From Synthetic PRR Agonists to the Potential of Defective Interfering Particles of Viruses
por: Vasou, Andri, et al.
Publicado: (2017)

Recent Developments in SARS-CoV-2 Neutralizing Antibody Detection Methods
por: Banga Ndzouboukou, Jo-Lewis, et al.
Publicado: (2021)

Liposome-Based Adjuvants for Subunit Vaccines: Formulation Strategies for Subunit Antigens and Immunostimulators
por: Tandrup Schmidt, Signe, et al.
Publicado: (2016)

Liposomal delivery system/adjuvant for tuberculosis vaccine
por: Moradi, Melika, et al.
Publicado: (2023)

A Dual TLR Agonist Adjuvant Enhances the Immunogenicity and Protective Efficacy of the Tuberculosis Vaccine Antigen ID93
por: Orr, Mark T., et al.
Publicado: (2014)

Toll like-receptor agonist Pam(3)Cys modulates the immunogenicity of liposomes containing the tuberculosis vaccine candidate H56
por: Kennerknecht, Kathrin, et al.
Publicado: (2020)

Adjuvants Differentially Modulate the Immunogenicity of Lassa Virus Glycoprotein Subunits in Mice
por: To, Albert, et al.
Publicado: (2022)

Synthesis of plant-based, self-adjuvanted, dual antigen specific to Mycobacterium tuberculosis as a novel tuberculosis subunit vaccine that elicits immunogenicity in rabbit
por: Yadav, Jyoti, et al.
Publicado: (2023)

Liposomal formulation of Gp41 derivate with adjuvant MPLA: vaccine design, immunogenicity in animals and safety in humans
por: Katinger, D, et al.
Publicado: (2012)

Role of Fused Mycobacterium tuberculosis Immunogens and Adjuvants in Modern Tuberculosis Vaccines
por: Junqueira-Kipnis, Ana Paula, et al.
Publicado: (2014)

Protective Efficacy and Immunogenicity of Rv0351/Rv3628 Subunit Vaccine Formulated in Different Adjuvants Against Mycobacterium tuberculosis Infection
por: Kwon, Kee Woong, et al.
Publicado: (2023)

Immunogenicity and protection effects of cationic liposome containing imiquimod adjuvant on leishmaniasis in BALB/c mice
por: Mehravaran, Ahmad, et al.
Publicado: (2019)

Safety and immunogenicity of an MF59™-adjuvanted subunit influenza vaccine in elderly Chinese subjects
por: Li, Rongcheng, et al.
Publicado: (2008)

Analysis of the safety and immunogenicity profile of an azoximer bromide polymer-adjuvanted subunit influenza vaccine.
por: Kompier, Ronald, et al.
Publicado: (2022)

Pseudo-Response Regulator (PRR) Homologues of the Moss Physcomitrella patens: Insights into the Evolution of the PRR Family in Land Plants
por: Satbhai, Santosh B., et al.
Publicado: (2011)

Adjuvants and Antigen-Delivery Systems for Subunit Vaccines against Tuberculosis
por: Mustafa, Abu Salim
Publicado: (2021)

Mimicking immune signatures of flavivirus infection with targeted adjuvants improves dengue subunit vaccine immunogenicity
por: Bidet, Katell, et al.
Publicado: (2019)

Effects of Adjuvants on the Immunogenicity and Efficacy of a Zika Virus Envelope Domain III Subunit Vaccine
por: Wang, Xinyi, et al.
Publicado: (2019)

The Systematic Review and Meta-Analysis on the Immunogenicity and Safety of the Tuberculosis Subunit Vaccines M72/AS01(E) and MVA85A
por: Ullah, Inayat, et al.
Publicado: (2020)

Enhancement of Mucosal Immunogenicity of Viral Vectored Vaccines by the NKT Cell Agonist Alpha-Galactosylceramide as Adjuvant
por: Singh, Shailbala, et al.
Publicado: (2014)

Injection Vaccines Formulated with Nucleotide, Liposomal or Mineral Oil Adjuvants Induce Distinct Differences in Immunogenicity in Rainbow Trout
por: Rømer Villumsen, Kasper, et al.
Publicado: (2020)

Cancer: A Tale of Aberrant PRR Response
por: Nagi, Raunaq Singh, et al.
Publicado: (2014)

Enhancement of the Immunogenicity and Protective Efficacy of a Mucosal Influenza Subunit Vaccine by the Saponin Adjuvant GPI-0100
por: Liu, Heng, et al.
Publicado: (2012)

Adjuvant Effect of Cationic Liposomes for Subunit Influenza Vaccine: Influence of Antigen Loading Method, Cholesterol and Immune Modulators
por: Barnier-Quer, Christophe, et al.
Publicado: (2013)

Engineered trivalent immunogen adjuvanted with a STING agonist confers protection against Trypanosoma cruzi infection
por: Sanchez Alberti, Andrés, et al.
Publicado: (2017)

Therapeutic efficacy against Mycobacterium tuberculosis using ID93 and liposomal adjuvant formulations
por: Baldwin, Susan L., et al.
Publicado: (2022)

Discovery of a novel target for cancer: PRR14
por: Xiao, Shaowen, et al.
Publicado: (2016)

PRR11 in Malignancies: Biological Activities and Targeted Therapies
por: Han, Wei, et al.
Publicado: (2022)

Author Correction: Mimicking immune signatures of flavivirus infection with targeted adjuvants improves dengue subunit vaccine immunogenicity
por: Bidet, Katell, et al.
Publicado: (2019)

Designing Adjuvant Formulations to Promote Immunogenicity and Protective Efficacy of Leptospira Immunoglobulin-Like Protein A Subunit Vaccine
por: Techawiwattanaboon, Teerasit, et al.
Publicado: (2022)

Liposomes as Adjuvants and Vaccine Delivery Systems
por: Tretiakova, D. S., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_a3iftcshj2fl9lh04b3npbfcno